A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer

Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada

NCT06361563 ·Status: COMPLETED

Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.

NCT03784040 ·Status: UNKNOWN ·Phase: PHASE1

Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence

NCT03443856 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

NCT04021108 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

NCT03776487 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC

NCT06034964 ·Status: ACTIVE_NOT_RECRUITING

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

NCT02935634 ·Status: COMPLETED ·Phase: PHASE2

Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours

NCT05043714 ·Status: COMPLETED ·Phase: PHASE1

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

NCT04006262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

NCT06235164 ·Status: ACTIVE_NOT_RECRUITING

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

NCT05111626 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)

NCT03675737 ·Status: COMPLETED ·Phase: PHASE3

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

NCT05535569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer

NCT06253611 ·Status: RECRUITING ·Phase: PHASE2

Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)

NCT03591731 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

NCT03042611 ·Status: COMPLETED ·Phase: PHASE3

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

NCT02370849 ·Status: COMPLETED ·Phase: PHASE2

Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer

NCT02179463 ·Status: UNKNOWN

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

NCT03615326 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma

NCT06440811 ·Status: COMPLETED

Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer

NCT00519324 ·Status: COMPLETED ·Phase: PHASE2

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

NCT06956716 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

NCT06093425 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer

NCT03647969 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction

NCT05918419 ·Status: UNKNOWN ·Phase: PHASE2